Weight-loss drugs fill a treatment gap for women with hormone disorder PCOS, doctors say

Women with PCOS seek relief in weight-loss drugs

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo Nordisk to manage the hormonal disorder's symptoms.

GLP-1 weight-loss drugs surge among women with PCOS as prescriptions soar

Women with polycystic ovary syndrome (PCOS) are increasingly turning to blockbuster weight-loss drugs from Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) to manage symptoms associated with the hormonal disorder, according to an analysis of U.S. patient records and interviews with obesity specialists and gynecologists. U.S. prescriptions for these GLP-1 drugs among women with PCOS have risen more than sevenfold since 2021, a review of 120 million …